» Articles » PMID: 33239407

Relative Contributions of Family History and a Polygenic Risk Score on COPD and Related Outcomes: COPDGene and ECLIPSE Studies

Overview
Date 2020 Nov 26
PMID 33239407
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Family history is a risk factor for chronic obstructive pulmonary disease (COPD). We previously developed a COPD risk score from genome-wide genetic markers (Polygenic Risk Score, PRS). Whether the PRS and family history provide complementary or redundant information for predicting COPD and related outcomes is unknown.

Methods: We assessed the predictive capacity of family history and PRS on COPD and COPD-related outcomes in non-Hispanic white (NHW) and African American (AA) subjects from COPDGene and ECLIPSE studies. We also performed interaction and mediation analyses.

Results: In COPDGene, family history and PRS were significantly associated with COPD in a single model (P <0.0001; P<0.0001). Similar trends were seen in ECLIPSE. The area under the receiver operator characteristic curve for a model containing family history and PRS was significantly higher than a model with PRS (p=0.00035) in NHWs and a model with family history (p<0.0001) alone in NHWs and AAs. Both family history and PRS were significantly associated with measures of quantitative emphysema and airway thickness. There was a weakly positive interaction between family history and the PRS under the additive, but not multiplicative scale in NHWs (relative excess risk due to interaction=0.48, p=0.04). Mediation analyses found that a significant proportion of the effect of family history on COPD was mediated through PRS in NHWs (16.5%, 95% CI 9.4% to 24.3%), but not AAs.

Conclusion: Family history and the PRS provide complementary information for predicting COPD and related outcomes. Future studies can address the impact of obtaining both measures in clinical practice.

Citing Articles

Clinical characteristics and outcomes of chronic obstructive pulmonary disease patients with family history of chronic airway disease.

Liu C, Song Q, Peng Y, Cheng W, Lin L, Li T Ann Med. 2025; 57(1):2477299.

PMID: 40074698 PMC: 11905302. DOI: 10.1080/07853890.2025.2477299.


Exploring the genetics of airflow limitation in lung function across the lifespan - a polygenic risk score study.

Hernandez-Pacheco N, Kilanowski A, Kumar A, Curtin J, Olvera N, Kress S EClinicalMedicine. 2024; 75:102731.

PMID: 39568778 PMC: 11577569. DOI: 10.1016/j.eclinm.2024.102731.


Prevalence, mortality and risk factors for self-reported COPD among smokers and never smokers, NHANES 1999-2018.

Li X, Xue M, Xu D, Fan C, Zhang J Tob Induc Dis. 2024; 22.

PMID: 39297054 PMC: 11409450. DOI: 10.18332/tid/192745.


Proteomic networks and related genetic variants associated with smoking and chronic obstructive pulmonary disease.

Konigsberg I, Vu T, Liu W, Litkowski E, Pratte K, Vargas L BMC Genomics. 2024; 25(1):825.

PMID: 39223457 PMC: 11370252. DOI: 10.1186/s12864-024-10619-1.


Polygenic risk scores identify heterogeneity in asthma and chronic obstructive pulmonary disease.

Moll M, Sordillo J, Ghosh A, Hayden L, McDermott G, McGeachie M J Allergy Clin Immunol. 2023; 152(6):1423-1432.

PMID: 37595761 PMC: 10841234. DOI: 10.1016/j.jaci.2023.08.002.


References
1.
Parr D, Stoel B, Stolk J, Stockley R . Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency. Thorax. 2006; 61(6):485-90. PMC: 2111224. DOI: 10.1136/thx.2005.054890. View

2.
Park J, Hobbs B, Crapo J, Make B, Regan E, Humphries S . Subtyping COPD by Using Visual and Quantitative CT Imaging Features. Chest. 2019; 157(1):47-60. PMC: 6965698. DOI: 10.1016/j.chest.2019.06.015. View

3.
Hersh C, Hokanson J, Lynch D, Washko G, Make B, Crapo J . Family history is a risk factor for COPD. Chest. 2011; 140(2):343-350. PMC: 3198493. DOI: 10.1378/chest.10-2761. View

4.
Vestbo J, Anderson W, Coxson H, Crim C, Dawber F, Edwards L . Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J. 2008; 31(4):869-73. DOI: 10.1183/09031936.00111707. View

5.
Lambert S, Abraham G, Inouye M . Towards clinical utility of polygenic risk scores. Hum Mol Genet. 2019; 28(R2):R133-R142. DOI: 10.1093/hmg/ddz187. View